tetraiodothyroacetic acid has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Candelotti, E; ChangOu, CA; Chu, HR; Chung, CC; Davis, PJ; De Luca, R; Huang, CH; Huang, HM; Huang, TY; Incerpi, S; Lee, SY; Li, WS; Li, ZL; Lin, CY; Lin, HY; Pedersen, JZ; Wang, K; Whang-Peng, J; Yang, YSH | 1 |
| Bharali, DJ; Davis, FB; Davis, PJ; Lin, HY; Meng, R; Mousa, SA; Tang, HY; Yalcin, M | 1 |
2 other study(ies) available for tetraiodothyroacetic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Terpenes; Thyroxine | 2022 |
Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Female; Humans; Injections, Intraperitoneal; Integrin alphaVbeta3; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Thyroid Hormones; Thyroxine; Xenograft Model Antitumor Assays | 2012 |